Category: Drug industry

2 5/23/2016

Inside the Sausage Factory of Drug Approval: Nuplazid (pimavanserin) coverage didn’t inspect closely enough

1 4/26/2016

Cross-border media comparison: Insurance coverage linked to news coverage of expensive cystic fibrosis drug

4/14/2016

Some news media wake up to problematic Belsomra ads; most hit the snooze button

4 3/16/2016

Coverage of Amarin off-label promotion agreement should have acknowledged deadly history of such marketing

1 3/10/2016

Xarelto controversy highlights need for more transparency at NEJM

10 3/8/2016

Investigation of Alzheimer’s Association in-fighting didn’t address the role of corporate sponsorships

3 3/1/2016

“Low T” tease: rosy anecdotes and the reality of testosterone treatment effects

1 2/29/2016

Precision Medicine at one year: A soaring White House summit and the potholes ahead

13 2/24/2016

TIME’s short memory on Alzheimer’s drug failures

7 2/10/2016

Groups push pharma agenda under the guise of patient advocacy